Kezar Life Sciences Organization
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Industry:
PharmTech
Technology:
Data-driven Technologies
Funding Status:
IPO
Investment Stage:
N/A
Estimated Revenue:
$1M to $10M
Investors Number:
10
Headquarters:
South San Francisco, California, United States
Employee Number:
11-50
Number Of Exists:
N/A
Investor Type:
Healthcare Company
Total Funding:
$78.3M
Founded Date:
2015
Last Funding Type:
Series B